EA
LLY icon

Evolution Advisers’s Eli Lilly LLY Stock Holding History

Evolution Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Buy
+3
New +$3.06K ﹤0.01% 161
2022
Q1 		– Sell
-75
Closed -$20K – 156
2021
Q4 		$20K Buy
+75
New +$19K 0.01% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evolution Advisers's LLY Position: Q2 2026 in Review

Evolution Advisers opened a new position in Eli Lilly (LLY) in Q2 2026: 3 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #161 among its holdings. This is a return to the name: Evolution Advisers previously reported a position in LLY as recently as Q4 2021.

Evolution Advisers first reported a position in LLY in Q4 2021 and has held it in 2 quarters since. The position peaked at $20K in Q4 2021. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Evolution Advisers held 3 shares of Eli Lilly worth $3K as of Q2 2026.
  • Eli Lilly was a new Evolution Advisers position in Q2 2026.
  • Eli Lilly made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #161 holding.
  • Evolution Advisers first reported a position in Eli Lilly in Q4 2021 and has held it in 2 quarters since.
  • Evolution Advisers's Eli Lilly position peaked at $20K in Q4 2021.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.